Comorbid illnesses and health care utilization among Medicare beneficiaries with lung cancer

Dy, Sydney M.; Sharkey, Phoebe D.; Herbert, Robert J.; Haddad, Kathleen; Wu, Albert W.

doi:10.1016/j.critrevonc.2006.04.001

Cited by 35 publications

(31 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…One study mentioned that congestive heart failure can indirectly impact survival because of its association with nonreceipt of cancer treatment (4). Patients with congestive heart failure were found significantly less likely to receive surgery or chemotherapy than patients without CHF (29). This partially explained why CHF has greater impact on localized stage lung cancer (HR, 1.731) compared with its decreased impact in regional stage (HR, 1.258) and distant stage (HR, 1.186) since the decision to proceed with surgery, the treatment of choice in this stage is affected by the presence or absence of CHF.…”

Section: Discussionmentioning

confidence: 99%

Comorbidity and Survival in Lung Cancer Patients

Islam

Jiang

Anggondowati

et al. 2015

Cancer Epidemiology, Biomarkers &Amp; Prevention

161

118

View full text Add to dashboard Cite

Background: As the population of the United States ages, there will be increasing numbers of lung cancer patients with comorbidities at diagnosis. Comorbid conditions are important factors in both the choice of the lung cancer treatment and outcomes. However, the impact of individual comorbid conditions on patient survival remains unclear.Methods: A population-based cohort study of 5,683 first-time diagnosed lung cancer patients was captured using the Nebraska Cancer Registry (NCR) linked with the Nebraska Hospital Discharge Data (NHDD) between 2005 and 2009. A Cox proportional hazards model was used to analyze the effect of comorbidities on the overall survival of patients stratified by stage and adjusting for age, race, sex, and histologic type.Results: Of these patients, 36.8% of them survived their first year after lung cancer diagnosis, with a median survival of 9.3

show abstract

Section: Discussionmentioning

confidence: 99%

Comorbidity and Survival in Lung Cancer Patients

Islam

Jiang

Anggondowati

et al. 2015

Cancer Epidemiology, Biomarkers &Amp; Prevention

161

118

View full text Add to dashboard Cite

show abstract

“…The most frequent was COPD found in 10% of the patients followed by other malignancies (9.1%), diabetes (6.1%), cerebrovascular disease (4.6%), and peripheral vascular disease (3.6%). In a series of 4447 elderly Medicare beneficiaries with lung cancer [3], 39% had COPD and 13% had congestive heart failure (CHF). In a series of 484 cases of small cell lung cancer (SCLC) diagnosed at the Innsbruck University Hospital and associated institutions between 1991 and 2011 [4], cardiovascular disease was present in 56.9%, COPD in 51.9%, other malignancies in 19.7%, diabetes in 19.7%, neurologic disease including stroke in 11.9% and renal failure in 7.4%.…”

Section: Introductionmentioning

confidence: 99%

Medical anticancer treatment of lung cancer associated with comorbidities: A review

Sculier¹,

Botta²,

Bucalau³

et al. 2015

Lung Cancer

View full text Add to dashboard Cite

“…There has been an increasing interest in the treatment of elderly patients with lung cancer [5,6,10,[13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31]. However, clinical information regarding lung cancer patients aged 80 years and over has not been fully available since such patients are not usually included in clinical trials and retrospective care analysis.…”

Section: Discussionmentioning

confidence: 99%

“…In addition, there was unchanged proportion of patients with poor PS and advanced disease at presentation aged 80 years or older. Aging is associated with a high prevalence of comorbid diseases [17,18,27,31]. Particularly those patients with a long smoking history are predisposed to comorbid diseases such as chronic obstructive pulmonary disease and cardiovascular disease, as well as other smoking-related malignancies [19].…”

Section: Discussionmentioning

confidence: 99%